Global stomach cancer deaths decline, colorectal cancer deaths stagnate - and more news

Tuesday, October 6, 2020

Hematology-Oncology News:

  1. Divergent findings with paclitaxel and nab-paclitaxel in TNBC (https://bit.ly/33vemjS)
  2. Palbociclib plus letrozole improves PFS in advanced endometrial cancer (https://bit.ly/2GIUl08)
  3. Global stomach cancer deaths decline as colorectal cancer deaths stagnate, rise (https://bit.ly/33zBVs1)

You can email the show at [email protected] and you can learn more about the show at https://www.mdedge.com/podcasts/blood-cancer

Podcast Participants

David Henry, MD
David Henry, MD, FACP, is a clinical professor of medicine at the University of Pennsylvania and vice chairman of the department of medicine at Pennsylvania Hospital in Philadelphia. He received his bachelor’s degree from Princeton University and his MD from the University of Pennsylvania, then completed his internship, residency, and fellowship at the Hospital of the University of Pennsylvania. After 2 years as an attending in the U.S. Air Force, he was drawn to practicing as a hem-onc because of the close patient contact and interaction, and his belief that, win or lose with each patient, one can always make a difference in their care and lives. Follow Dr. Henry on Twitter: @davidhenrymd. Dr. Henry reported being on the advisory board for Amgen, AMAG Pharmaceuticals, and Pharmacosmos. He reported institutional funding from the National Institutes of Health and FibroGen.